HENNION & WALSH ASSET MANAGEMENT, INC. – Supernus Pharmaceuticals, Inc. Transaction History
HENNION & WALSH ASSET MANAGEMENT, INC. portfolio value:
$4.12M
portfolio value
HENNION & WALSH ASSET MANAGEMENT, INC. quarter portfolio value change:
+17.05%
quarter
Supernus Pharmaceuticals, Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Decrease | -5.35% | -6.88K shares | 401K | $33.85 | 121.83K |
| Q2 2022 | share | Decrease | -36.49% | -73.96K shares | -2.82M | $28.92 | 128.71K |
| Q1 2022 | share | Decrease | -6.62% | -14.36K shares | 222K | $32.32 | 202.68K |
| Q4 2021 | share | Decrease | -11.42% | -27.98K shares | -206K | $30.03 | 217.04K |
| Q3 2021 | share | Decrease | -3.14% | -7.94K shares | -1.25M | $26.67 | 245.02K |
| Q2 2021 | share | Increase | +0.54% | 1.36K shares | 1.20M | $30.79 | 252.96K |
| Q1 2021 | share | Increase | 0.00% | 251.60K shares | 6.58M | $26.18 | 251.60K |